SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.400
-0.010 (-0.71%)
May 7, 2026, 3:58 PM HKT
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 1.96 billion as of May 7, 2026. Its market cap has increased by 58.48% in one year.
Market Cap
1.96B
Enterprise Value
1.91B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.40
Market Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 1.96B, a decrease of -67.62%. That is a compound annual growth rate of -15.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 1.94B | 4.48% |
| Dec 31, 2025 | 1.86B | 56.14% |
| Dec 31, 2024 | 1.19B | -31.56% |
| Dec 29, 2023 | 1.74B | -7.18% |
| Dec 30, 2022 | 1.87B | -34.91% |
| Dec 31, 2021 | 2.88B | -37.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 2.78B |
| HighTide Therapeutics | 2.30B |
| Frontage Holdings | 1.99B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Mabpharm | 1.86B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.72B |
| Beijing Biostar Pharmaceuticals | 1.71B |
| Cutia Therapeutics | 1.66B |